CLINICAL AND RADIOGRAPHIC OUTCOMES AFTER 3 YEARS OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引:0
|
作者
Genovese, Mark C. [1 ]
van Adelsberg, Janet [2 ]
van Hoogstraten, Hubert [3 ]
Iglesias-Rodriguez, Melitza [4 ]
Mangan, Erin K. [2 ]
Graham, Neil [2 ]
Spindler, Alberto [5 ]
机构
[1] Stanford Univ, Immunol & Rheumatol, Stanford, CA 94305 USA
[2] Regeneron Pharmaceut, Immunol & Inflammat, Tarrytown, NY USA
[3] Sanofi Genzyme, Immunol & Inflammat, Bridgewater, NJ USA
[4] Sanofi Genzyme, Rheumatol, Bridgewater, NJ USA
[5] Univ Nacl Tucuman, Immunol & Rheumatol, San Miguel De Tucuman, Tucuman, Argentina
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
O03
引用
收藏
页码:27 / 28
页数:2
相关论文
共 50 条
  • [21] Pooled Safety and Efficacy of Sarilumab in Rheumatoid Arthritis Patients 65 Years of Age and Older
    Fleischmann, Roy
    Genovese, Mark C.
    van Adelsberg, Janet
    Mangan, Erin
    Iglesias-Rodriguez, Melitza
    Dukovic, Deborah
    Huizinga, T. W. J.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [22] EFFICACY OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO PREVIOUSLY RECEIVED SARILUMAB OR TOCILIZUMAB
    Emery, Paul
    van Hoogstraten, Hubert
    Jayawardena, Shyamalie
    Mangan, Erin
    Cejas, Paula
    Verschueren, Patrick
    RHEUMATOLOGY, 2018, 57
  • [23] Efficacy of Sarilumab in Patients with Rheumatoid Arthritis Who Previously Received Sarilumab or Tocilizumab
    Emery, Paul
    van Hoogstraten, Hubert
    Jayawardena, Shyamalie
    Mangan, Erin K.
    Cejas, Paula
    Verschueren, Patrick
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] Clinical Implications of Understanding Radiographic Findings in Relation to Clinical Outcomes in Rheumatoid Arthritis
    Keystone, Edward C.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 : 11 - 16
  • [25] Clinical images:: Radiographic progression of rheumatoid arthritis over twenty years
    del Rincón, I
    Roldán, JF
    ARTHRITIS AND RHEUMATISM, 1999, 42 (11): : 2498 - 2498
  • [26] Efficacy and safety of sarilumab in patients with active rheumatoid arthritis
    McCarty, Delilah
    Robinson, April
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (03) : 61 - 67
  • [27] ONSET OF ACTION OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN 2 PHASE 3 STUDIES
    Fleischmann, R.
    Mangan, E. K.
    van Adelsberg, J.
    Fay, J.
    van Hoogstraten, H.
    Bauer, D.
    Thompson, D.
    Kivitz, A.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 733 - 733
  • [28] ASSOCIATION BETWEEN CLINICAL AND RADIOGRAPHIC RESPONSES, AND PHYSICAL FUNCTION IN A PHASE 3 STUDY OF SARILUMAB PLUS METHOTREXATE IN PATIENTS WITH ACTIVE, MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS
    Genovese, M. C.
    van Hoogstraten, H.
    Kampman, W.
    Jayawardena, S.
    Huizinga, T. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 576 - 577
  • [29] ONSET OF ACTION OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN 2 PHASE 3 STUDIES
    Fleischmann, R.
    Mangan, E.
    Van Hoogstraten, H.
    Kivitz, A.
    Burmester, G.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 28 - 28
  • [30] RELATIONSHIP BETWEEN CLINICAL RESPONSE AND RADIOGRAPHIC OUTCOMES IN PATIENTS WITH MODERATE RHEUMATOID ARTHRITIS IN THE PRESERVE TRIAL
    Bananis, E.
    Smolen, J.
    Van Vollenhoven, R.
    Pederson, R.
    Szumski, A.
    Koenig, A.
    INTERNAL MEDICINE JOURNAL, 2013, 43 : 15 - 16